DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM

Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on ...

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That DexCom, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action la ...

Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc.

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered DexCom losses, you mayCLICK HEREor copy and paste the following link into your browser: ...
FierceBiotech

Dexcom hit by FDA Class I recall for its continuous glucose monitoring system app

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous glucose monitoring system app, leading the FDA to issue its most serious recall notice. A “software defect in ...
Nasdaq

DexCom (DXCM) G6 CGM System Now Available to TRICARE Members

DexCom, Inc. DXCM recently announced that its G6 continuous glucose monitoring (“CGM”) System will be available to diabetic military members, their families and retirees as a TRICARE brand-name ...
Nasdaq

Dexcom (DXCM) Launches G6 Glucose Monitoring System in Canada

Dexcom, Inc. DXCM announced that its Dexcom G6 CGM System would be available for all eligible patients with type 1 and type 2 diabetes in the Canadian province, Manitoba, irrespective of their age. It ...